This HTML5 document contains 61 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
n9http://dx.doi.org/10.1136/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57265349
rdf:type
wikibase:Item
schema:description
im September 2011 veröffentlichter wissenschaftlicher Artikel article by Gert Van Assche et al published 23 September 2011 in Gut wetenschappelijk artikel наукова стаття, опублікована у вересні 2011
p:P577
wds:Q57265349-8169FAF3-08F6-4A8B-BC3B-7129AED8AE7E
wdt:P577
2011-09-23T00:00:00Z
p:P407
wds:Q57265349-71C862D5-3498-4BB8-8004-74414F81C1C4
wdt:P407
wd:Q1860
p:P2093
wds:Q57265349-D1817C14-B324-40CD-B162-7767538224E5 wds:Q57265349-8F2F682F-2511-4517-B4E9-523E62BBA32A wds:Q57265349-6EC95C78-49ED-4652-BD37-14A22DBE9BAD wds:Q57265349-AC80EA6B-2DD9-4788-8F8F-BFF75661C55D wds:Q57265349-51E0B230-31D2-48F6-960E-269C2EA93D07 wds:Q57265349-282FF3C8-668B-4231-B368-61343E2E9381 wds:Q57265349-149563E9-EAD8-4D04-91B4-8BFD36AD6AAF wds:Q57265349-18CD80EA-79D6-4AE8-8CC4-6574D61AD185
wdt:P2093
Frederik Gabriels Vera Ballet Evelien Humblet Maja Noman Ann Gils Christophe Claessens Niels Vande Casteele Séverine Vermeire
rdfs:label
Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial
skos:prefLabel
Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial
schema:name
Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial
p:P50
wds:Q57265349-04F8CBA2-E3BF-4DB2-A3CB-FA4022889FAD wds:Q57265349-38D990DB-A95B-40EF-968F-B80F6B8C98FA wds:Q57265349-463B9AE4-C2AD-4757-BB93-A0CC4D5A0012
wdt:P50
wd:Q30247987 wd:Q37066728 wd:Q37064266
p:P1476
wds:Q57265349-36997AF3-9953-4B0A-9218-B81E71668538
wdt:P1476
Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial
p:P304
wds:Q57265349-3998DBF4-DE60-4A12-84EF-A34BD65B9A89
wdt:P304
229-234
p:P31
wds:Q57265349-EC7EC7DF-479A-46AF-A55C-CBE38DBA9C94
wdt:P31
wd:Q13442814
p:P921
wds:Q57265349-D234E97E-3243-497F-BFD4-1853D04459C2 wds:Q57265349-B789A999-386F-4D8B-A239-5D34319CC25E wds:Q57265349-C8AC25BC-A9E9-4FB5-B721-9E489FB6BF79
wdt:P921
wd:Q348260 wd:Q1472 wd:Q181600
p:P698
wds:Q57265349-6233D603-1AF9-4E16-9024-A665BF8C67F0
wdtn:P698
n12:21948942
wdt:P698
21948942
p:P1433
wds:Q57265349-2D11C17B-CFB7-4464-9D36-6E811A25CEEE
wdt:P1433
wd:Q5621669
p:P433
wds:Q57265349-59C8B55F-F0B3-480D-8D8E-030189321942
p:P478
wds:Q57265349-59AF4288-B253-4EC6-925F-51C4BF9933CC
wdt:P433
2
wdt:P478
61
p:P356
wds:Q57265349-9BB89B29-EF3F-4F95-9F22-BC10413C74B7
wdtn:P356
n9:GUTJNL-2011-300755
wdt:P356
10.1136/GUTJNL-2011-300755